Genzyme 10K 2008 Annual report | GZTR Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	6th grade Avg

New words: adequacy, Africa, allogeneic, alpha, amello, ampule, Appendix, apply, assistant, Award, Bain, balance, Bamforth, bind, bioburden, Biomedical, biopharmaceutical, biosimilar, British, burden, capability, Cardiometabolic, Cephalon, Chemokine, cited, Cleveland, CMC, CMHP, compassionate, computer, consultant, cooperatively, Critical, David, DesRosier, diagnosed, difficulty, digestive, diligent, Dodge, dollar, drilling, Duke, DuPont, economical, Education, efficient, endocrine, engineer, enhance, EU, explore, external, fairly, Farmaceutici, Fellowship, fifteen, framework, fully, galactosidase, Geraghty, GMP, GTC, Hakko, hand, hematopoietic, highest, Hodgkin, Hong, inInternal, jason, journal, Kong, Kyowa, Lumizyme, lymphoma, Malaysia, Meeker, microbiological, MM, mobilization, mobilize, mobilizing, Monovisc, Mount, myeloablative, myeloma, myelosuppressive, nationwide, NHL, notice, Nuclear, observed, offshore, Ohio, oil, outpatient, Palmer, paper, patchwork, PDUFA, peripheral, pharmacy, pill, plerixafor, polymer, potency, presence, prGCD, proceed, professor, progenitor, prognostic, proposed, quantitative, regular, rituximab, Roxane, Russia, satisfaction, satisfactory, Sato, Schering, Scotland, Sea, Sensipar, sensitization, simultaneously, Sinai, source, Sponsoring, stem, stimulating, substance, supervision, suspension, threshold, timeline, transmitted, Treadway, Treanda, tumor, unauthorized, unfavorable, University, upfront, Venezuela, verbal, verification, Vested, vial, warning, whisky, writing, yield

Removed: abdominopelvic, aplastic, appointed, Asian, assessment, ATGAM, attestation, audit, automation, biochemical, bioresorbable, Biotech, Brewery, calling, carrot, case, caution, ceased, CellTech, Central, chart, CMS, College, compared, comparing, convenience, Convertible, counseling, Cystic, cytogenetic, cytometry, DCOR, demonstrated, direction, dismissal, dismissed, District, DNA, driven, Eastern, electronically, elimination, episode, evaluating, exercised, expressed, extremely, fair, filled, film, Florida, flow, fziomed, Gel, Gemayel, globulin, GmbH, HHS, host, immunohistochemistry, immunosuppressant, Indenture, internet, introduction, Japanese, LabCorp, Los, managed, marked, Marketable, marrow, MAST, mature, mg, Monrovia, motion, nearby, necessitate, negative, NIH, Novazyme, offered, operation, Orange, Ortho, Orthoclone, perception, Pfizer, plaintiff, polyclonal, Portugal, prGCB, proficiency, purified, purported, qualification, Quest, rabbit, realized, recommended, refer, REPEL, reputation, respiratory, Revisited, Room, sample, SangStat, screening, secure, serving, Simulect, Society, solid, Somatic, specialty, spine, Spraygel, statistically, stayed, Supplementary, SurgiWrap, Tampa, tracking, transformed, transplanted, trustee, UCB, undergo, undertaken, unilaterally, varying, verigen, vigorously, vii, Westborough, Zenapax



/s/ MICHAEL S. WYZGA Chief Financial Officer February 27, 2009

Genzyme (GZTR) Inactive 10-K2008 FY Annual report

Content analysis